Phase 2 trial of three schedules of CUE-101 administered before surgery or chemoradiotherapy in HLA-A*0201 positive patients with HPV16+ OPSCC.Jesse M. Zaretsky, Douglas Adkins, Riley Mullins et al.|Journal of Clinical Oncology|2023Cited by 2